Footnotes
[1] Senate
Hansard May 9, 1996 p 624
[2] Senate
Hansard, May 21, 1996, p 821
[3] Probe a prescription for social concern, The
Australian, 31 January, 2006, p.12
[4] Dr Graham and Ms Halton, Department of Health and
Ageing, CA Hansard, 15 December 2005, pages 30-31.
[5] Submission 1012, Southern Cross Bioethics
Institute.
[6] Editorial: No excuse for wilful ignorance. The
Sydney Morning Herald, 4 January 2006.
[7] Christie Peuker, We will fight for service:
senator. Shepparton News, 3 November 2005.
[8] Submission 920, Women's Forum Australia, page 21.
[9] Submission 635, Jenny Madden
[10] Byden-Brown, Sarah, Morning-after pill on
sale. The Australian, 1 July 2002.
[11] Submission 920, Women's Forum Australia
[12] Ms Mongan, Australian Federation of Right to Life
Associations, CA Hansard, 3 February 2006, page 23.
[13] Submission 920, Women's Forum
Australia, page 16.
[14] Submission 1012, Southern Cross Bioethics
Institute, page 3.
[15] Dr Tippett, CA Hansard, 15 December 2005, page
39.
[16] Dr Page, CA Hansard, 15 December 2005, page 28.
[17] See discussion with the AMA, the Rural Doctors
Association and the Royal Australian and New Zealand College of Obstetricians
and Gynaecologists about how a woman aborting at home could dispose of her
foetus. CA Hansard, 15 December 2005.
[18] Submission 240, Dr Elvis Seman, page 2.
[19] Bishop Anthony Fisher, CA Hansard, 6 February
2006, page 11, 13.
[20] Dr Graham and Ms Halton, Department of Health and
Ageing, CA Hansard, 15 December 2005, pages 30-31.
[21] Franks,
CES (2004), Putting accountability and responsibility back into the system of
government. Policy Options, October.
Page 64.
[22] De Costa, CM (2005) Medical abortion for Australian
women: it's time. Medical Journal of Australia, Vol 183(7), pages 378-380.
[23] Submission 901, Dr Sharman Stone.
Melissa Polimeni, Chance
of abortion backdown. Herald Sun, 14 October 2005
[24] Christie Peuker, We will fight for service:
senator. Shepparton News, 3 November 2005.
[25] RU-486 (Mifepristone) – Medical Abortion. Minute to the Minister. Department of Health and Ageing, November
2005.
[26] Women's Abortion Action Campaign, submission 905,
page 10.
[27] Submission 635, Ms Jenny Madden, page 1.
[28] Submission 1, Dr David Gawler, page 1.
[29] Dr Seman, CA Hansard, 3 February 2006, page
51-52.
[30] Dr Graham and Ms Halton, Department of Health and
Ageing, CA Hansard, 15 December 2005, pages 30-31.
[31] See: http://www.tga.gov.au/docs/html/recruit/empcond.htm
[32] Probe a prescription for social concern, The
Australian, 31st January, 2006, p.12
[33] Submission 920, Women's Forum Australia, page 21.
See also submission 930.
[34] Submission 920, Women's Forum Australia, page 21.
[35] Submission 635, Jenny Madden, page 2.
[36] Byden-Brown, Sarah, Morning-after pill on
sale. The Australian, 1 July 2002.
[37] National Drugs and Poisons Schedule Committee (Therapeutic Goods
Administration), Record of reasons 38th Meeting 17-19 June 2003 - http://www.tga.gov.au/ndpsc/record/rr200306.htm.
[38] Price, Sarah, Morning-after pill sold by a beauty
consultant. Sun-Herald, 30 May 2004.
Spagnolo, Joe, Morning after pill. The
Sunday Times (Perth), 8 January 2006.
[39] Submission
628, Life Office, Catholic Archdiocese of Sydney, page 5.
[40] Submission 930, Dr Renate Klein, page 7.
[41] Submission 240, Dr Elvis Seman, page 2.
[42] Submission 240, Dr Elvis Seman, page 3.
[43] Patricia Karvelas, Abortion warning by drug's
producer. The Australian, 31 January 2006.
[44] Submission 920, Women's Forum Australia, page 13.
[45] Submission
623, Drs Dianne and Stephen Grocott, pages 1 and 2.
[46] Submission 240, Dr Elvis Seman, page 2.
[47] Dr Andrew Pesce, Australian Medical Association,
CA Hansard, 15 December 2005, page 9.
[48] Submission 920, Women's Forum Australia, page
15.
[49] The Bill, clause 3.
[50] http://www.tga.gov.au/docs/html/bringmed/apendixa.htm
Appendix A, subsection (d). TGA information on drugs subject to import
controls, dated 6.2.06.
[51] Committee
Hansard 6 February 2006, p.78 (Dr Weisberg, SHFPA).
[52] Report on the Provisions of the Research
Involving Embryos and Prohibition of Human Cloning Bill 2002, October 2002.
[53] Paragraph 1.6 notes that RU486 is just one of the
class of medicines defined as restricted goods.
[54] Explanatory memorandum, p.1.
[55] Luke Buckmaster, 'RU486 for Australia?', Research Note, no. 19, Parliamentary
Library, 28 November 2005, p.2. https://www.aph.gov.au/Library/pubs/rn/2005-06/06rn19.pdf
[56] Committee
Hansard, 15 December 2005, pp 20-21 (TGA).
[57] Research
Note, no. 19, Parliamentary Library, 28 November 2005, pp.3-4.
[58] Committee
Hansard , 15 December 2005, p. 4 (AMA); Committee
Hansard , 15 December 2005, pp. 54-55 (RANZCOG); Submission 401, p.3 and Attachment 4 (RANZCOG).
[59] Submission
401, p. 3 (RANZCOG).
[60] Submission
401, Attachment 2, p. 16 (RANZCOG).
[61] Committee
Hansard , 15 December 2005, pp.3-4 (AMA). Submissions 3, pp.1-3 (Prof de Costa); 930, pp.6-9 (Istar Ltd).
[62] Committee
Hansard , 15 December 2005, p.5 (AMA), 37 and 40 (RDAA).
[63] MM Gary and DJ Harrison Analysis of severe adverse events related to the use of Mifepristone as
an abortifacient Annals of Pharmacotherapy Vol 40 (February 2006).
I.M. Spitz et al. Early Pregnancy
Termination with Mifepristone and Misoprostol in the United States New
England Journal of Medicine Vol 338 (1998)1241-1247. Submissions 401, Attachment 2, p. 17 (RANZCOG); 930, p. 4 (Dr
Renate Klein).
[64] M.F. Greene Fatal infections associated with
mifepristone-induced abortion. New England Journal of Medicine Vol 353
(2005)2317-2318.
[65] Committee
Hansard 3 February 2006, p.39 (PHAA); Submission
401, p.3 (RANZCOG).
[66] Committee
Hansard, 15 December 2005, p. 51 (Rural Doctors Association of Australia).
[67] Committee
Hansard , 15 December 2005, p. 4 (AMA).
[68] Submission
907, pp.2-3 (Sexual Health and Family Planning Australia); Committee Hansard, 15 December 2005, p. 2 (AMA).
[69] Committee
Hansard, 15 December 2005, p. 2 (AMA); Submission
712 (name withheld); Submission 907,
p. 3 (Sexual Health and Family Planning Australia); Submission 1004, p. 2 (RACP Australasian Chapter of Sexual Health
Medicine); Submission 603, p. 2
(Monash University Department of Obstetrics and Gynaecology); 704, p.3 (RCA).
[70] Mifepristone: Drug Information at www.uptodate.com
[71] The Australian, 31 January 2006, p.3.
[72] Committee
Hansard 3 February 2006, p.48 (Dr Seman).
[73] Committee
Hansard 6 February 2006, p.72 (Dr Weisberg, SHFPA).
[74] Submission
413, p. 1-2 (Australian Family Association (NSW)); Submission 975, p. 2-3 (Mr Geoffrey Bullock); Submission 1111, p.2-3 (The Australian
Catholics Bishops Conference, The Bishops Committee for the Family and for Life
(ACT)).
[75] For example, re Claratyne “It may be an
unfortunate analogy. I can see your point: I can see that that particular
analogy is not a good one” Dr Taft, Public Health Association, Public Hearing,
Melbourne, 3 February 2006 CA 39; “Senator BARNETT—Is it a fair comparison? Ms
Crozier [Women’ Health NSW]—On the way you are presenting it, I would say no,
and I accept that-”, Public Hearing, Sydney, 6 February 2006 CA19.
[76] Mifeprex Product Label at:
http://www.fda.gov/cder/foi/label/2000/20687lbl.htm
[77] M.F. Greene, Fatal infections associated with
mifepristone-induced abortion. New England Journal of Medicine Vol 353
(2005)2317-2318.
[78] Submission
701, p.3 (Dr Cockburn).
[79] Submission
919, pp.1-2 (Dr Robyn Seth-Purdie). Also Submission
4, p.1 (NFAW).
[80] Submissions
707, p.1 (PHAA); 1086, p.3 (Liberty Victoria).
[81] Eg Submissions
3, p.2 (Prof de Costa); 601, p.3 (ARHA); 902, p.1 (Dr Wainer); 1004, p.2
(ACSHM).
[82] Submission
905, p.10 (WAAC).
[83] Submission
1004, p.2 (ACSHM).
[84] Submission
202. p.2 (Professors Rogers, Ankeny and Dodds).
[85] Submission
916, p.2 (WHV).
[86] Submission
902, p.1 (Dr Wainer).
[87] Submission
608, p.1 (WCFGP Rich). Also Submission
905, p.9 (WAAC).
[88] Submission
401, p.2 (RANZCOG)
[89] Submission
903, p.2 (RWH, Melbourne).
[90] Submission
1003, p.2 (AMA).
[91] Submission
402, p.2 (WHNSW); 419, p.2 (Hobart WHC); 917, p.5 (Children by Choice); 1000,
p.3 (NUS).
[92] Submission
402, p1 (WHNSW). Also Submission 4,
p.4 (NFAW); 922, p.1 (WIRE)
[93] Submission
908, p.3 (RACGP).
[94] Submissions
706, p.4 (IFPACA); 708, p.1 (RWH&FPV); 901, p.5 (Dr Stone); 907, p.2
(SH&FPA).
[95] Submission
202, p.1 (Profs Rogers Ankeny and Dodds).
[96] Eg Submissions
701, p.2 (Dr Cockburn); 708, pp.1-3 (RWH&FPV); 907, pp.1-2 (SH&FPA);
916, pp.1-2 (WHV); 1085, p.2 (VCOSS).
[97] Submission
704, p.1 (RCA).
[98] Submission
907, p.1 (SH&FPA). See also Submission
4, p.1 (NFAW); 1004, p.1 (ACSHM).
[99] Submission
907, p.1 (SH&FPA). See also Submission
4, p.1 (NFAW); 1004, p.1 (ACSHM).
[100] Submission
602, p.5 (Istar Ltd).
[101] Submissions
708, p.3 (RWH&FPV); 1085, p.2 (VCOSS).
[102] Submission
701, p.1 (Dr Cockburn).
[103] Submission
907, p.3 (SH&FPA); 1003, p.2 (AMA).
[104] Submission
1004, p.1 (ACSHM).
[105] Submission
603 (Professor David Healy). These trials were referred to in other
submissions including 601, p.2 (ARHA)
[106] Submissions
10, p.1 (PHAA); 402, pp.2-4 (WHNSW); 917, p.3 (Children by Choice Association);
1000, p.3 (NUS);
[107] Submissions
10, p.2 (PHAA); 401, p.3 (RANZCOG); 601, p.2 (ARHA); 701, p.2
(Dr Cockburn).
[108] Reproductive Choice Australia noted that RU486
is not the only medicine capable of harming an embryo/fetus or causing
miscarriage. Currently, the TGA lists around 55 drugs or categories of drugs
that either 'cause, are suspected to have caused or may be expected to cause an
increased incidence of human fetal malformations or irreversible damage'
(Category D) or have 'a high risk of causing permanent damage to the fetus'
(Category X). Submission 704, p.3.
[109] Submission
401, pp.3-4 (RANZCOG).
[110] Green, See also Committee Hansard 15 December 2005, p.38 (RANZCOG).
[111] Slayter EK, Sullivan EA & King JF, Maternal Death in Australia 1997-1999,
AIHW Cat. N. PER 24, Sydney 2004: AIHW National Perinatal Statistics Unit,
p.xiv.
[112] Submission
1001, pp.4-5 (The Association of Reproductive Health Professionals).
[113] Submission
706, p.3 (Dr Fiala, FIAPAC).
[114] Committee Hansard 6 February 2006, p.76
(Sydney Centre for Reproductive Health Research, Sexual Health and Family
Planning Australia). See also Hogan SF, Ireland K, 'Fatal acute spontaneous
endometritis resulting from Clostridium
sordellii', American Journal of Clinical Pathology 1989; 91:104-106;
McGregor JA, Soper DE, Lovell G, Todd JK, 'Maternal deaths associated with Clostridium sordellii infection, American Journal of Obstetrics and
Gyneocology 1989; 161:987-995; Abdulla A, Yee L, 'The clinical spectrum of Clostridium sordellii bacteraemia: two
case reports and a review of the literature', Journal of Clinical Pathology, 2000; 53:709-12; Omphalitis. Patrick
G Gallagher, MD, Samir S Shah, MD <http://www.emedicine.com/ped/topic1641.htm>
accessed Jan 2006-02-07; Kainer, MA, Linden, JV, Whaley DN, Holmes, HT, Jarvis,
WR, Jernigan, DB Archibald LK, 'Clostridium infections associated with
Musculosketetal-Tissue Allografts', New
England Journal of Medicine, Vol 350 (25) 2564-2571.
[115] Greene
M, 'Fatal Infections Associated with Mifepristone-Induced Abortion', New
England Journal of Medicine, 353:22, 2317-2318. See also an interview with
Dr Greene at transcript http://www.abc.net.au/rn/talks/8.30/helthrpt/stories/s1521375.htm
[116] Research
Note, no. 19, Parliamentary Library, 28 November 2005, p.1.
[117] Submission
919,pp.2-3 (Dr Seth-Purdie).
[118] Submission
701, p.5 (Dr Cockburn). Also Submission
901, p.2 (Dr Stone).
[119] Submissions
401, p.3 (RANZCOG); 903, p.3 (RWH Vic); 922, p.1 (WIRE); 1003, p.3 (AMA).
[120] Submissions
1003, p.3 (AMA); 402, p.4 (WHNSW); 917, pp.4-5 (Children by Choice).
[121] Submission
602, p.5 (Istar Ltd).
[122] Eg Submissions
917, p.4 (Children by Choice); 922, p.2 (WIRE).
[123] Submission
908, pp.3-4 (RACGP).
[124] Submission
903, p.3 (RWH).
[125] Submissions
401, p.5 (RANZCOG); 903, p.3 (RWH)
[126] Submissions
602, pp.3-5 (Istar Ltd); 708, p.2 (RWH&FPV).
[127] Submission
204, p.1 (Professor Pettigrew).
[128] Submission
608, p.2 (Women’s Clinic and Family General Practice on Richmond Hill, Vic).
[129] Submission
606, p.1 (Broome Regional Aboriginal Medical Service)
[130] Submission
911, p.4 (RDAA). Also Submission 901,
p.3 (Dr Stone); 905, p.8 (WAAC).
[131] Submission
921, p.1. (AARN).
[132] Submission
911, p.4 (RDAA).
[133] Submission
905, p.6 (WAAC).
[134] Submission
419, p.2 (Hobart Women's Health Centre).
[135] Submission
3, p.2 (Professor de Costa).
[136] Submission
605, pp.2-3 (FPQ). Also Submission
917, p.2 (Children by Choice Qld).
[137] Submission
703, pp.1-2 (People for Choice Tasmania).
[138] Submission
1085, p.3 (VCOSS).
[139] Submission
606, p.1 (Broome Regional Aboriginal Medical Service).
[140] Submission
1003, p.3 (AMA).
[141] Submission
4, p.4 (NFAW).
[142] Submission
207, p.1 (QBC). See also Submission
720, p.1 (RLOCAM.
[143] Submission
421, p.3 (AFRTLA).
[144] Submission
628, p.2 (Catholic Archdiocese of Sydney). Also Submissions 411, p.1 (CWLA); 420, p.1 (FoL); 627, p.4 (RTLA).
[145] Submission
930, p.4 (Dr Klein).
[146] Submissions
931, p.3 (aaRU486); 933, p.5 (CDAV); 1111, pp2-3 (ACBC)
[147] Submission
930, p.12 (Dr Klein).
[148] Submission
628, p.2 (Catholic Archdiocese of Sydney). Also Submissions 720, p.1 (RLOCAM); 938, p.2 (Lutheran Church of
Australia).
[149] Submission
931, p.3 (aaRU486). See also Submission
240, p.3 (Dr Seman).
[150] Submission
421, p.5 (AFRTLA).
[151] Submission
1111, p.3 (ACBC).
[152] Submission
420, p.1 (Festival of Light).
[153] Submission
5, p.5 (WFDRHL).
[154] Submission
411, p.3 CWLA).
[155] Submission
421, p.10 (AFRTLA). See also Submissions
636, p.2 (Salt Shakers); 931, p.2 (aaRU486)
[156] Submission
930, pp1-2 (Dr Klein).
[157] Submissions
207, p.1 (QBC); 420, p.5 (FoL); 421, p.9 (AFRTLA).
[158] Submission
1012, p.2 (SCBI).
[159] Submission
930, p.2 (Dr Klein). See also Submission
240, p.1 (Dr Elvis Seman).
[160] Submission
931, p.1 (aaRU486).
[161] Submissions
240, pp.2-3 (Dr Seman); 930, pp.7-11 (Dr Klein)
[162] Committee
Hansard 3 February 2006, p. (Mr Richard Egan, Festival of Light).
[163] Committee
Hansard 3 February 2006, p.28 (Dr Piercy, RTLA).
[164] Submissions
5, pp.6-7 (WFDRHL); 421, p.8 (AFRTLA); 627, pp.7-8 (RTLA); 628, p.5 (Catholic
Archdiocese of Sydney); 636, pp.2-4 (Salt Shakers); 720, p.2 (RLOCAM); 722,
pp2-5 (Dr Lennon); 931, p.5 (aaRU486); 933, pp.2-4 (CDAV);
[165] Letter to the U. S. Food and Drug Administration
on Mifeprex, aka “RU-486”
At: http://reform.house.gov/CJDPHR/News/DocumentSingle.aspx?DocumentID=38547
[166] Rep. Bartlett Wins Support to Ban Abortion
Pill,Thursday, February 02, 2006 By Elissa Petruzzi at:
http://www.foxnews.com/story/0,2933,183520,00.html
[167] The Times (London), 1 February 2006.
[168] Sinave et al Toxic
shock syndrome due to Clostridium sordellii Clinical Infectious Diseases
Vol 35 (2002) 1441-1443
[169] Committee
Hansard 3 February 2006, p.73 (Mr Richard Egan, Festival of Light).
[170] Submission 410, p.3 (CMF).
[171] Submission
623, pp.1-2 (Drs Stephen and Dianne Grocott).
[172] Submissions 420, p.2 (FoL); 720, p.3 (RLOCAM); 934,
p.2 (NCC).
[173] Submission
933, p.5 (CDAV).
[174] Submission
930, p.11 (Dr Klein).
[175] Submission
5, p.5 (WFDRHL).
[176] Submission
636, p.5 (Salt Shakers).
[177] Submission
635, p.1 (Ms Jenny Madden).
[178] Committee
Hansard 6 February 2006, p.44 (Dr Buist).
[179] Committee
Hansard 3 February 2006, p.29 (Dr Piercy, RTLA).
[180] Media release, Minister for Health and Ageing,
15 November 2005, ABB140/05.
[181] Submission
933, p.4 (CDAV). See also Submission
628, pp.4-5 (Catholic Archdioceses of Sydney).
[182] Submissions
5, p.4 (WFDRHL); 207, p.2 (QBC); 627, p.4 (RTLA).
[183] Submission
628, p.3 (Catholic Archdiocese of Sydney).
[184] Submission
920, pp.4-6 (WFA).
[185] Submission
623, p.1 (Drs Stephen and Dianne Grocott).
[186] Submission
628, pp.3-4 (Catholic Archdiocese of Sydney).
[187] Submission
1012, p.2 (SCBI). See also Submissions
628, p.4 (Catholic Archdiocese of Sydney); 722, p.9 (Dr Lennon); 933, p.6
(CDAV).
[188] Submission
1012, p.3 (SCBI).
[189] Submission
725, p.2 (Dr Seman).
[190] Submission
5, p.7 (WFDRHL).
[191] Submission
623, p.2 (Drs Stephen and Dianne Grocott).